4 Jul 2023 08:02
Regulatory News Release
4 July 2023
Croda successfully completes acquisition of Solus Biotech
Â
Croda International Plc ('Croda') today confirms that, following receipt of unconditional approval from the South Korean regulatory authorities, it has now successfully completed the acquisition of Solus Biotech, a global leader in premium, biotechnology-derived active ingredients for beauty care and pharmaceuticals.
Â
This follows the announcement on 6 February 2023 that Croda had reached an agreement to acquire Solus Biotech.
Â
-ENDS-
Â
Further information:
Investors: David Bishop, Croda +44 7823 874428
Media: Charlie Armitstead, Teneo +44 7703 330269
Â
About Croda:
Croda is the company that uses smart science to create high performance ingredients and technologies that improve lives. For more information see: www.croda.com.
Â